Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMID 10561177)

Published in J Clin Oncol on April 01, 1999

Authors

M Thomas1, C Rübe, M Semik, M von Eiff, L Freitag, H N Macha, W Wagner, F Klinke, H H Scheld, N Willich, W E Berdel, K Junker

Author Affiliations

1: Department of Hematology/Oncology and Respiratory Medicine, Westfälische-Wilhelms Universität, Muenster, Germany. mthomas@uni-muenster.de

Articles citing this

Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg (2005) 1.60

[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation]. Pathologe (2004) 1.53

[Bronchial carcinoma. Epidemiology, diagnosis and therapy]. Internist (Berl) (2003) 1.38

Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer. Br J Cancer (2004) 1.07

Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. Br J Cancer (2004) 0.94

Prognostic factors and long term results of neo adjuvant therapy followed by surgery in stage IIIA N2 non-small cell lung cancer patients. Ann Thorac Med (2009) 0.93

Neoadjuvant radiotherapy/chemoradiotherapy in locally advanced non-small cell lung cancer. Balkan Med J (2015) 0.93

[Correlation of histologic results with PET findings for tumor regression and survival in locally advanced non-small cell lung cancer after neoadjuvant treatment]. Pathologe (2005) 0.83

Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer. Ann Thorac Surg (2015) 0.83

[Cellular changes in non-small cell lung cancer after neoadjuvant therapy]. Pathologe (2004) 0.80

[Apoptosis and tumor regression in locally advanced non-small cell lung cancer with neoadjuvant therapy]. Pathologe (2003) 0.80

Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer. Br J Cancer (2002) 0.78

How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer. Br J Cancer (2007) 0.77

[Small cell lung cancer: pathology and molecular pathology]. Pathologe (2009) 0.75

Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment. Thorac Surg Sci (2011) 0.75

[Therapy-induced tumor regression and regression grading in lung cancer]. Pathologe (2014) 0.75

Articles by these authors

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science (2000) 9.92

Transport of hemolysin across the outer membrane of Escherichia coli requires two functions. J Bacteriol (1983) 4.27

Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents. Eur Respir J (2006) 3.89

Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol (2001) 3.22

Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene (1999) 3.01

Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood (2000) 2.70

Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group. BMJ (2000) 2.69

Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood (2000) 2.48

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys (2000) 2.33

Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax (2009) 2.28

Transport of hemolysin by Escherichia coli. J Cell Biochem (1983) 2.23

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Ann Oncol (2002) 2.14

ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society. Eur Respir J (2002) 2.12

Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial. Eur Respir J (2011) 2.09

[Anesthesia for minimal invasive coronary surgery without employing extracorporeal circulation]. Anasthesiol Intensivmed Notfallmed Schmerzther (1997) 2.01

Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J Cancer Res Clin Oncol (1997) 1.91

Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys (1995) 1.87

VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer (2008) 1.84

Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood (2000) 1.81

Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood (2001) 1.76

Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. J Clin Oncol (2003) 1.75

Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys (2000) 1.72

Frameless neuronavigation in intracranial endoscopic neurosurgery. J Neurosurg (2001) 1.72

High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial. J Clin Oncol (2004) 1.70

Pore formation by the Escherichia coli hemolysin: evidence for an association-dissociation equilibrium of the pore-forming aggregates. Infect Immun (1989) 1.69

Global monitoring of wetlands--the value of ENVISAT ASAR Global mode. J Environ Manage (2008) 1.68

Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res (1998) 1.66

Single-agent carboplatinum for advanced seminoma. A phase II study. Cancer (1993) 1.63

Intrafocal (Kapandji) pinning of distal radius fractures with and without external fixation. J Hand Surg Am (1998) 1.61

Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function. Blood (2001) 1.60

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

A controlled comparison of two treatments for nocturnal enuresis. J Pediatr (1982) 1.54

Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol (2000) 1.53

Intraoperative radiofrequency ablation of chronic atrial fibrillation: a left atrial curative approach by elimination of anatomic "anchor" reentrant circuits. J Cardiovasc Electrophysiol (1999) 1.52

Advantages of short-lived positron-emitting radioisotopes for intracoronary radiation therapy with liquid-filled balloons to prevent restenosis. J Nucl Med (2001) 1.52

Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy (2008) 1.51

Control of SIV rebound through structured treatment interruptions during early infection. Science (2000) 1.48

[Current issues in pulmonary pathology. Report of the working group on pulmonary pathology of the German Society of Pathology]. Pathologe (2012) 1.46

Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System. Clin Endocrinol (Oxf) (2007) 1.42

Ex situ resection of primary cardiac tumors. Thorac Cardiovasc Surg (2003) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

In vitro and in vivo comparative colonization of Staphylococcus aureus and Staphylococcus epidermidis on orthopaedic implant materials. Biomaterials (1989) 1.41

Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma--results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol (2001) 1.41

Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias or syncope: results of programmed ventricular stimulation and long-term follow-up. Circulation (1997) 1.39

Creation of a self-made total artificial heart using combined components of available ventricular assist devices. Thorac Cardiovasc Surg (2008) 1.39

[Recommendations on the therapy of bronchial carcinoma]. Pneumologie (2002) 1.39

Non-destructive evaluation of prosthetic heart valves by holographic interferometry. J Heart Valve Dis (1993) 1.38

Clinical relevance of intracranial microembolic signals in patients with left ventricular assist devices. A prospective study. Stroke (1996) 1.37

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Diagnosis and treatment of nonocclusive mesenteric ischemia after open heart surgery. Ann Thorac Surg (2001) 1.32

Radical resection of cardiac sarcoma. Thorac Cardiovasc Surg (2004) 1.31

Impact of malignant hematological disorders on cardiac surgery. Cardiovasc Surg (2000) 1.30

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer. Br J Cancer (2008) 1.27

Case report: Kasabach-Merritt syndrome: a review of the therapeutic options and a case report of successful treatment with radiotherapy and interferon alpha. Br J Radiol (2002) 1.26

Biotechnology and the European public. Nat Biotechnol (2000) 1.25

Systemic anaphylaxis--separation of cardiac reactions from respiratory and peripheral vascular events. Res Exp Med (Berl) (1990) 1.25

Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia. Leukemia (2006) 1.24

Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells. Br J Haematol (2000) 1.23

The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer (2001) 1.22

Nonclostridial gas gangrene. Report of 48 cases and review of the literature. JAMA (1975) 1.20

Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19

Grading of tumor regression in non-small cell lung cancer : morphology and prognosis. Chest (2001) 1.18

Surgical management of extensive lipomatous hypertrophy of the right atrium. Cardiovasc Surg (2000) 1.16

Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res (2001) 1.16

Leiomyosarcoma of the pulmonary artery--a diagnostic chameleon. Eur J Cardiothorac Surg (2001) 1.16

Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger. J Pathol (2007) 1.14

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer. Br J Cancer (2008) 1.14

Respiratory failure due to tracheobronchomalacia. Thorax (1996) 1.14

Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients. J Clin Oncol (1998) 1.14

Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent. Mol Cell Biol (2000) 1.14

Incidence and pathogenesis of late aneurysms after patch graft aortoplasty for coarctation. J Thorac Cardiovasc Surg (1986) 1.14

[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14

Hard and soft tissue reactions to ITI screw implants: 3-year longitudinal results of a prospective study. Int J Oral Maxillofac Implants (1998) 1.13

Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13

Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study. Med Pediatr Oncol (1999) 1.13

Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12

Single-incision implantation of cardioverter defibrillators using nonthoracotomy lead systems. Ann Thorac Surg (1994) 1.12

Good engraftment of B-cell precursor ALL in NOD-SCID mice. Klin Padiatr (1997) 1.12

First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11

Abnormal glomerular filtration rate, renal plasma flow, and renal protein excretion in recent and short-term diabetics. Br Med J (1972) 1.10

Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG). Ann Oncol (2005) 1.10

Pathological fractures of the mandible. A review of the etiology and treatment. Int J Oral Maxillofac Surg (1998) 1.10

Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J (1994) 1.09

Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis. Cytotherapy (2008) 1.09

The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia. Leukemia (2007) 1.09

Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors. Clin Cancer Res (1998) 1.09

Histotomography of the odontoblast processes at the dentine-enamel junction of permanent healthy human teeth in the confocal laser scanning microscope. Clin Oral Investig (1998) 1.08

High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group. J Clin Oncol (1999) 1.08

Biphasic defibrillation using a single capacitor with large capacitance: reduction of peak voltages and ICD device size. Pacing Clin Electrophysiol (1996) 1.08

Ion mobility spectrometry in the diagnosis of sarcoidosis: results of a feasibility study. J Physiol Pharmacol (2007) 1.08

Tension subcutaneous emphysema. Anesthesiology (1985) 1.08

Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07